Flora Growth Corp. (FLGC)
USD 0.46
(0.62%)
USD 0.46
(0.62%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | -713 Thousand USD | 86.78% |
| 2022 | -5.39 Million USD | 85.13% |
| 2021 | -36.27 Million USD | -143.89% |
| 2020 | -14.87 Million USD | -1351.14% |
| 2019 | 1.18 Million USD | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q1 | 1.5 Million USD | 311.36% |
| 2024 Q2 | -548 Thousand USD | -134.04% |
| 2023 FY | -713 Thousand USD | 86.78% |
| 2023 Q3 | -1.64 Million USD | -203.2% |
| 2023 Q1 | -1.31 Million USD | 75.57% |
| 2023 Q4 | -713 Thousand USD | 56.68% |
| 2023 Q2 | 1.59 Million USD | 221.02% |
| 2022 Q4 | -5.39 Million USD | -109.31% |
| 2022 Q3 | -2.57 Million USD | 60.71% |
| 2022 Q1 | 37.61 Million USD | 203.69% |
| 2022 Q2 | -6.55 Million USD | -117.44% |
| 2022 FY | -5.39 Million USD | 85.13% |
| 2021 Q1 | 15.52 Million USD | 203.82% |
| 2021 FY | -36.27 Million USD | -143.89% |
| 2021 Q2 | -18.46 Million USD | -218.92% |
| 2021 Q4 | -36.27 Million USD | 0.0% |
| 2020 Q4 | -14.95 Million USD | 0.0% |
| 2020 Q3 | -14.95 Million USD | -151.94% |
| 2020 Q2 | -5.93 Million USD | -4342.39% |
| 2020 Q1 | 139.89 Thousand USD | 0.0% |
| 2020 FY | -14.87 Million USD | -1351.14% |
| 2019 FY | 1.18 Million USD | 0.0% |
| 2019 Q2 | - USD | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| Bright Green Corporation | 1.84 Million USD | 138.714% |
| Alpha Teknova, Inc. | 1.97 Million USD | 136.12% |
| ANI Pharmaceuticals, Inc. | 94.2 Million USD | 100.757% |
| Aquestive Therapeutics, Inc. | 74.95 Million USD | 100.951% |
| Collegium Pharmaceutical, Inc. | 435.33 Million USD | 100.164% |
| Cosmos Health Inc. | 8.59 Million USD | 108.3% |
| Journey Medical Corporation | -9.7 Million USD | 92.656% |
| Embecta Corp. | 1.31 Billion USD | 100.054% |
| Esperion Therapeutics, Inc. | 458.69 Million USD | 100.155% |
| Dynavax Technologies Corporation | 106.63 Million USD | 100.669% |
| Intra-Cellular Therapies, Inc. | -130.82 Million USD | 99.455% |
| Pacira BioSciences, Inc. | 432.74 Million USD | 100.165% |
| PainReform Ltd. | -7.95 Million USD | 91.031% |
| Sunshine Biopharma, Inc. | -15.63 Million USD | 95.44% |
| Sunshine Biopharma, Inc. | -15.63 Million USD | 95.44% |
| SCYNEXIS, Inc. | -19.35 Million USD | 96.315% |
| Safety Shot Inc | -2.28 Million USD | 68.788% |
| China SXT Pharmaceuticals, Inc. | -9.42 Million USD | 92.439% |
| Procaps Group, S.A. | 242.93 Million USD | 100.293% |
| Theratechnologies Inc. | 24.87 Million USD | 102.867% |
| Harrow Health, Inc. | 116.41 Million USD | 100.612% |
| Sonoma Pharmaceuticals, Inc. | -2.52 Million USD | 71.706% |
| Biofrontera Inc. | 4.05 Million USD | 117.579% |
| DURECT Corporation | -7.65 Million USD | 90.685% |
| Supernus Pharmaceuticals, Inc. | -33.52 Million USD | 97.873% |
| Cronos Group Inc. | -663.32 Million USD | 99.893% |
| OptiNose, Inc. | 58.06 Million USD | 101.228% |
| Ironwood Pharmaceuticals, Inc. | 623.38 Million USD | 100.114% |
| Kala Pharmaceuticals, Inc. | -14.57 Million USD | 95.107% |
| RedHill Biopharma Ltd. | -5.18 Million USD | 86.252% |
| Organogenesis Holdings Inc. | 15.01 Million USD | 104.749% |
| Guardion Health Sciences, Inc. | -6.35 Million USD | 88.789% |
| Cumberland Pharmaceuticals Inc. | 106.85 Thousand USD | 767.234% |
| Radius Health, Inc. | 359.28 Million USD | 100.198% |
| Universe Pharmaceuticals INC | 197.2 Thousand USD | 461.545% |
| ProPhase Labs, Inc. | 19.23 Million USD | 103.708% |
| Phibro Animal Health Corporation | 454.84 Million USD | 100.157% |
| Procaps Group S.A. | 242.93 Million USD | 100.293% |
| Alvotech | 1.06 Billion USD | 100.067% |
| TherapeuticsMD, Inc. | 3.67 Million USD | 119.386% |
| Viatris Inc. | 17.13 Billion USD | 100.004% |
| Rockwell Medical, Inc. | 4.45 Million USD | 116.001% |
| Aytu BioPharma, Inc. | -4.87 Million USD | 85.38% |
| SIGA Technologies, Inc. | -148.68 Million USD | 99.52% |
| Tilray Brands, Inc. | 158.97 Million USD | 100.448% |
| Lifecore Biomedical, Inc. | 121.89 Million USD | 100.585% |
| Shineco, Inc. | 29.29 Million USD | 102.434% |
| PetIQ, Inc. | 351.93 Million USD | 100.203% |
| Regencell Bioscience Holdings Limited | -2.9 Million USD | 75.426% |
| Incannex Healthcare Limited | -5.48 Million USD | 87.001% |
| Neurocrine Biosciences, Inc. | 177.3 Million USD | 100.402% |
| Alimera Sciences, Inc. | 55.3 Million USD | 101.289% |
| Silver Spike Investment Corp. | -32.61 Million USD | 97.814% |
| Assertio Holdings, Inc. | -32.52 Million USD | 97.808% |
| Shuttle Pharmaceuticals Holdings, Inc. | -1.48 Million USD | 52.107% |
| Petros Pharmaceuticals, Inc. | -5.06 Million USD | 85.91% |
| Clever Leaves Holdings Inc. | -4.81 Million USD | 85.189% |
| Cyclo Therapeutics, Inc. | -8.21 Million USD | 91.319% |
| Avadel Pharmaceuticals plc | 4.21 Million USD | 116.908% |
| Hempacco Co., Inc. | 13.61 Million USD | 105.237% |
| Talphera, Inc. | -5.72 Million USD | 87.537% |
| Alvotech | 1.06 Billion USD | 100.067% |
| Eagle Pharmaceuticals, Inc. | 7.14 Million USD | 109.979% |
| Lantheus Holdings, Inc. | -96.71 Million USD | 99.263% |
| Currenc Group, Inc. | -16.57 Million USD | 95.698% |
| Kamada Ltd. | -46.43 Million USD | 98.464% |
| Indivior PLC | -33.95 Million USD | 97.9% |
| Evoke Pharma, Inc. | 260.57 Thousand USD | 373.627% |
| Cyclo Therapeutics, Inc. | -8.21 Million USD | 91.319% |
| Evolus, Inc. | 63.7 Million USD | 101.119% |
| HUTCHMED (China) Limited | -197.45 Million USD | 99.639% |
| Amphastar Pharmaceuticals, Inc. | 479.11 Million USD | 100.149% |
| Akanda Corp. | 3.9 Million USD | 118.259% |